March 09, 2010 Hiru Corporation(HIRU.PK)
Kinsley Street Investors interviews Hiru Corporation

1) Recently your company has had a lot of success in releasing both traditional and new treatments for hypertension and atherosclerosis. Given the high rate of atherosclerotic disease in the United States, are there any plans to move into that market? How will you advertise your product in new markets?

Hiru Corp: We see huge opportunities in the United States and other international markets for our products that address these ailments.

We believe that our strong competitive advantage is the quality of our proprietary Chinese medicines. To get this superior quality, naturally, we start from the raw materials of Chinese medicine. We first establish our own GAP planting base of traditional Chinese medicines. Only by establishing a company's own GAP planting base, can a company be assured of the quality of its Chinese herbal medicines. Our base uses a large number of organic fertilizers to control Chinese herbal pesticide residues and the iron content. This assures our superior quality for the United States and international markets. In our base, we have good quality raw and green pollution-free material sources, so the curative effects of our products meet consumer needs. This is how we will win and expand in these new markets.


2) KinsleyStreet Investors: What are your plans regarding international markets such as the United States, and will Hiru Corporation be seeking FDA approval for therapeutic use of your herbal medicines?

Hiru Corp: We take a long term view for entering the US market. First, we will pay more attention to the materials. We will introduce some specialized production equipment for the US and international markets using advanced management strategies. We will meet the quality requirements of international markets. In accordance with the U.S. international market requirements, we will apply for and obtain a procedure from the Food and Drug Administration that is recognized internationally. This will open the door to our expansion.


3) Kinsleystreet Investors: What are some of your company's goals for the next year, and what should investors and consumers be looking forward to?

Hiru Corp: Our plan next year is to use a mountain location to expand the cultivation areas of Chinese herbal medicines. We see our growth continuing to expand and we need to expand production to satisfy demand. We will do in-depth development of new products to satisfy the special demands of the international market. By enhancing our development to meet consumers' needs, we will promote the company's products to achieve our overall goal of reducing patient suffering.


4) KinsleyStreet Investors: Given that the herbal medicine market is expanding globally, how do you intend to compete for market share in the different economies? Which countries or geographic areas would you consider to be your mainstays and opportunities for future expansion?

Hiru Corp: We believe that we will win international recognition for the magical effects of our Chinese herbal medicines. We know that the quality of our products will win us more markets, so we focus on quality assurance. We prefer to enter into Southeast Asia -- Japan, Malaysia, Singapore, and others -- and other international markets like United States. In these markets, there is a larger market space for our products and we can continue to grow rapidly.


5) KinsleyStreet Investors: There are probably more than 50 drug companies trading publicly in the market today. What makes Hiru stand out?

Hiru Corp: We know there are many famous medicine companies, however, Hiru Corporation will gain from its unique advantages of the rich resources of our growing base and the excellent quality guaranty of our raw materials. The more the industry and consumers see our product quality, the more they will have confidence in our products and the more we will see our reputation growing rapidly.


6) KinsleyStreet Investors: What are some of the company goals short and long term?

Hiru Corp: Hiru Corporation’s short and long term goals are doing base planting and cultivation of Yao Miao, fully implementing GAP Management, expanding the planting area, expanding marketing sales of our finished medicine and giving Chinese Herbal Pieces and Intermediate Chinese Medicine Extract access to international markets.


7) KinsleyStreet Investors: On February 11th, your company filed a research report on the effects of your Guben Hutan Tongmai Herbal preparation on the development of atherosclerosis in rats and compared it with the leading synthetic treatment, simvastatin. Can you tell us a little bit about your plans to increase research awareness of the Tongmai formula in this treatment? How do you plan to utilize and publicize these advantages?

Hiru Corp: The number of people in the population with atherosclerosis and high blood lipid is relatively high. We have seen the good results of our Tongmai lipid-lowering tablets. These tablets are one of our breakthroughs and they are produced by our planting base. This will even more will strengthen our research and development of related products, expand product promotion, and improve the corporate image.


8) KinsleyStreet Investors: Can you please share with us some information about your cancer research and what you’re looking to accomplish with what you are learn from the research? How would your research benefit cancer patients?

Hiru Corp: These products are in the research and development stage; some details cannot be disclosed. Our aim is to plant some cancer medicine materials to produce medicine which cannot be found in parts of the medicine market. We believe this will greatly reduce patient suffering and this is the overall purpose of our efforts.


9) KinsleyStreet Investors: How do you plan on improving share holder value in the near future?

Hiru Corp: Our company will take full advantage of our unique production base, increase research, develop new medicines under their own brand, and establish our international brand. We are sure that as a result we will gratify our shareholders and our industry partners and that they will find themselves eager and excited to buy Hiru products.


10) KinsleyStreet Investors: What is the share structure for HIRU?

Hiru Corp: For our common shares, we have 888,000,000 authorized, 674,925,111 outstanding and 95,887,564 in the public tradeable float.





Visitors and investors with questions about Hiru Corporation are suggested to log into the chat room at http://chat.kinsleystreet.com for additional information

E-mail: dstreet@kinsleystreet.com